Prelude Capital Management, LLC Health Catalyst, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$5.53 - $7.28 $301,982 - $397,546
-54,608 Reduced 74.97%
18,227 $116,000
Q1 2024

May 15, 2024
BUY
$7.44 - $11.21 $356,718 - $537,474
47,946 Added 192.64%
72,835 $548,000
Q4 2023

Feb 14, 2024
BUY
$6.71 - $10.16 $167,005 - $252,872
24,889 New
24,889 $230,000
Q2 2022

Aug 15, 2022
BUY
$11.79 - $27.63 $195,489 - $458,133
16,581 New
16,581 $240,000
Q1 2020

May 15, 2020
SELL
$17.8 - $37.6 $5,340 - $11,280
-300 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$26.44 - $40.63 $7,932 - $12,189
300 New
300 $10,000

Others Institutions Holding HCAT

# of Institutions
170
Shares Held
49.7M
Call Options Held
2.86M
Put Options Held
56.4K
View Full List

About Health Catalyst, Inc.

HCAT Quotes by TradingView
  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $380M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email